Tag: IP

Investigating Unjustified Excipient Choice During Supplier Qualification In the pharmaceutical industry, the choice of excipients is critical to ensuring the quality, safety, and efficacy of the final product. An unjustified…

Addressing Functional Performance Failures during Supplier Qualification: A Comprehensive Investigation Approach In the pharmaceutical industry, ensuring the quality and compatibility of excipients during supplier qualification is critical for maintaining product…

Assessing the Risks of Unjustified Excipient Choices in Formulation Development In the pharmaceutical industry, excipients play a critical role in drug formulation, impacting API quality and overall product efficacy. However,…

Addressing Functional Performance Failures During Scale-Up: An Investigation Guide In the fast-paced world of pharmaceutical manufacturing, functional performance failures during scale-up can pose significant risks, particularly when they necessitate late-stage…

Understanding Functional Performance Failures During Scale-Up: Navigating Regulatory Expectations Functional performance failures during the scale-up of pharmaceutical manufacturing processes can not only derail production timelines but also trigger significant regulatory…

Understanding the Impact of Unverified Excipient Selection During Supplier Qualification Pharmaceutical manufacturers must remain vigilant in their choice of excipients, as unjustified selections can lead to significant compatibility issues and…

Investigation into Supplier Grade Substitutions During Regulatory Review: Strategies for CAPA Implementation The pharmaceutical sector is heavily regulated, emphasizing the need for rigorous quality compliance across all stages of product…

Addressing Supplier Grade Substitution During Formulation Development to Prevent Late-Stage Reformulation The pharmaceutical sector continually faces challenges related to material quality, particularly concerning supplier grade substitutions during formulation development. Such…

Examining the Overlooked Issue of Moisture Sensitivity in Supplier Qualification In the pharmaceutical manufacturing landscape, ensuring the quality of excipients is pivotal for API integrity and product efficacy. However, moisture…

Assessing Excipient Incompatibility with Active Pharmaceutical Ingredients during Formulation Development In pharmaceutical formulation development, the selection of excipients is critical as incompatible excipients can compromise the quality and efficacy of…

Addressing Variability in Excipient Grade During Formulation Development: An Investigation Framework The pharmaceutical industry continuously grapples with the intricacies of excipient variability, particularly during formulation development. Such variability can cause…

Assessing the Risks of Excipient Incompatibility with API During Scale-Up In the pharmaceutical manufacturing environment, the compatibility of excipients with active pharmaceutical ingredients (APIs) is critical, especially during scale-up processes.…